Detalhe da pesquisa
1.
MUC16 suppresses human and murine innate immune responses.
Gynecol Oncol
; 152(3): 618-628, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30626487
2.
Effective Combination of Innate and Adaptive Immunotherapeutic Approaches in a Mouse Melanoma Model.
J Immunol
; 198(4): 1575-1584, 2017 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28062694
3.
Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma.
Cancer Immunol Immunother
; 67(10): 1647-1658, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30073390
4.
Enhanced binding of necrosis-targeting immunocytokine NHS-IL12 after local tumour irradiation in murine xenograft models.
Cancer Immunol Immunother
; 65(8): 1003-13, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27376889
5.
Intratumoral hu14.18-IL-2 (IC) induces local and systemic antitumor effects that involve both activated T and NK cells as well as enhanced IC retention.
J Immunol
; 189(5): 2656-64, 2012 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22844125
6.
Enhancement of the anti-melanoma response of Hu14.18K322A by αCD40 + CpG.
Cancer Immunol Immunother
; 62(4): 665-75, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23151945
7.
Intratumoral treatment of smaller mouse neuroblastoma tumors with a recombinant protein consisting of IL-2 linked to the hu14.18 antibody increases intratumoral CD8+ T and NK cells and improves survival.
Cancer Immunol Immunother
; 62(8): 1303-13, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23661160
8.
NK cells engineered to express a GD2 -specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin.
J Cell Mol Med
; 16(3): 569-81, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21595822
9.
Phase II trial of hu14.18-IL2 for patients with metastatic melanoma.
Cancer Immunol Immunother
; 61(12): 2261-71, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22678096
10.
Translational immunoPET imaging using a radiolabeled GD2-specific antibody in neuroblastoma.
Theranostics
; 12(13): 5615-5630, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35966592
11.
Short-course neoadjuvant in situ vaccination for murine melanoma.
J Immunother Cancer
; 10(1)2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35039460
12.
Mechanism of effective combination radio-immunotherapy against 9464D-GD2, an immunologically cold murine neuroblastoma.
J Immunother Cancer
; 10(5)2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35618290
13.
Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A.
J Clin Oncol
; 40(4): 335-344, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34871104
14.
The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model.
Cancer Immunol Immunother
; 60(5): 731-8, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21340652
15.
Ab-IL2 fusion proteins mediate NK cell immune synapse formation by polarizing CD25 to the target cell-effector cell interface.
Cancer Immunol Immunother
; 60(12): 1789-800, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21792658
16.
Development of the clinical candidate PBD-C06, a humanized pGlu3-Aß-specific antibody against Alzheimer's disease with reduced complement activation.
Sci Rep
; 10(1): 3294, 2020 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32094456
17.
In situ Vaccine Plus Checkpoint Blockade Induces Memory Humoral Response.
Front Immunol
; 11: 1610, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32849544
18.
Phase I/II open-label study of the biologic effects of the interleukin-2 immunocytokine EMD 273063 (hu14.18-IL2) in patients with metastatic malignant melanoma.
J Transl Med
; 7: 68, 2009 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-19640287
19.
Linking antibody Fc domain to endostatin significantly improves endostatin half-life and efficacy.
Clin Cancer Res
; 14(5): 1487-93, 2008 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18316573
20.
Combining adoptive cellular and immunocytokine therapies to improve treatment of B-lineage malignancy.
Cancer Res
; 67(6): 2872-80, 2007 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17363611